Showing results (1741-1750 of 1,873) with videos related to

Sort By:
Pageof 188
Genes & Development|October 28, 2018
Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor developmentBrandon J Aubrey, Ana Janic, Yunshun Chen, et al.
Anatomia, Histologia, Embryologia|October 15, 2024
Dynamic Narrowing of the Diaphragmatic Vena Cava in Ovis ariesWilliam E Schwartzman, Mackenzie E Turner, J Logan Spiess, et al.
Cell Death & Disease|August 26, 2016
MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XLIngela B Vikström, Anne Slomp, Emma M Carrington, et al.
Schizophrenia Bulletin Open|August 18, 2020
A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social AffiliationKristen R Dwyer, Alexandra M Andrea, Christina L G Savage, et al.
Genomics|November 15, 2001
Complex high-resolution linkage disequilibrium and haplotype patterns of single-nucleotide polymorphisms in 2.5 Mb of sequence on human chromosome 21M Olivier, V I Bustos, M R Levy, et al.
Genetics|October 23, 2012
Dispensable, redundant, complementary, and cooperative roles of dopamine, octopamine, and serotonin in Drosophila melanogasterAudrey Chen, Fanny Ng, Tim Lebestky, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2022
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancerJustin A Chen, Jasmine C Huynh, Chun-Yi Wu, et al.
Clinical Schizophrenia & Related Psychoses|July 29, 2015
Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring DeviceDeanna L Kelly, Hadar Ben-Yoav, Gregory F Payne, et al.
Biochemical and Biophysical Research Communications|December 19, 2000
PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liverA Hermanowski-Vosatka, D Gerhold, S S Mundt, et al.
Journal of Medicinal Chemistry|June 6, 2008
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studiesGiuseppe La Regina, Felicia Diodata D'Auria, Andrea Tafi, et al.
Pageof 188